Literature DB >> 26324781

CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.

Jolanta Rybczynska1, Katherine Campbell2, Saleem Kamili3, Stephen Locarnini4, Krzysztof Krawczynski3, Christopher M Walker5.   

Abstract

Humans vaccinated with hepatitis B virus (HBV) surface antigen (HBsAg) sometimes develop humoral and cellular immunity to HBV proteins such as core and polymerase that are not vaccine components, providing indirect evidence that vaccine-induced immunity is not sterilizing. We previously described CD4(+) T-cell immunity against HBsAg and polymerase in chimpanzees after vaccination and HBV challenge. Here, vaccinated chimpanzees with protective levels of anti-HBsAg antibodies were rechallenged with HBV after antibody-mediated CD4(+) T-cell depletion. HBV DNA was detected in liver for at least 3 months after rechallenge, but virus replication was suppressed, as revealed by the absence of HBV DNA and HBsAg in serum. These observations provide direct virological evidence for nonsterilizing immunity in individuals with anti-HBsAg antibodies and are consistent with translation of HBV proteins to prime immune responses. They also indicate that CD4(+) T cells were not required for suppression of HBV replication in previously vaccinated individuals.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  CD4+ T cell; class II epitope; hepatitis B virus; persistence; sterilizing immunity; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26324781      PMCID: PMC4676542          DOI: 10.1093/infdis/jiv348

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals.

Authors:  Tanja Bauer; Klaus Weinberger; Wolfgang Jilg
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Vaccination in humans generates broad T cell cytokine responses.

Authors:  Stephen C De Rosa; Fabien X Lu; Joanne Yu; Stephen P Perfetto; Judith Falloon; Susan Moser; Thomas G Evans; Richard Koup; Christopher J Miller; Mario Roederer
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

3.  Decline of anti-HBs after hepatitis B vaccination and timing of revaccination.

Authors:  W Jilg; M Schmidt; F Deinhardt
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

4.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 5.  Epidemiology and prevention of hepatitis B.

Authors:  Miriam J Alter
Journal:  Semin Liver Dis       Date:  2003-02       Impact factor: 6.115

6.  HCV persistence and immune evasion in the absence of memory T cell help.

Authors:  Arash Grakoui; Naglaa H Shoukry; David J Woollard; Jin-Hwan Han; Holly L Hanson; John Ghrayeb; Krishna K Murthy; Charles M Rice; Christopher M Walker
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

Review 7.  Hepatitis B vaccine -- do we need boosters?

Authors:  J E Banatvala; P Van Damme
Journal:  J Viral Hepat       Date:  2003-01       Impact factor: 3.728

Review 8.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.

Authors:  A L Erickson; Y Kimura; S Igarashi; J Eichelberger; M Houghton; J Sidney; D McKinney; A Sette; A L Hughes; C M Walker
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

10.  Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections.

Authors:  Naglaa H Shoukry; John Sidney; Alessandro Sette; Christopher M Walker
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

View more
  2 in total

1.  Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies.

Authors:  Tomoko Honda; Sumiko Gomi; Daisuke Yamane; Fumihiko Yasui; Takuya Yamamoto; Tsubasa Munakata; Yasushi Itoh; Kazumasa Ogasawara; Takahiro Sanada; Kenzaburo Yamaji; Yasuhiro Yasutomi; Kyoko Tsukiyama-Kohara; Michinori Kohara
Journal:  mSphere       Date:  2021-05-12       Impact factor: 4.389

2.  Early events in hepatitis B infection: the role of inoculum dose.

Authors:  Stanca M Ciupe; Naveen K Vaidya; Jonathan E Forde
Journal:  Proc Biol Sci       Date:  2021-02-10       Impact factor: 5.349

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.